Last week, Arxada’s investor update on its proposed recapitalisation transaction included an anti-LME protection referring to Pfleiderer, for what appears to be the first time in reference to a European deal.
See 9fin’s analysis of the proposed A&E transaction here.
The proposed Pfleiderer protection appears intended to give creditors comfort that Arxada will not be able to move material or crown-jewel assets into unrestricted subsidiaries and leave noteholders and lenders looking at a hollowed-out credit group.
However, sources told 9fin that the market should resist treating this as a tick-box exercise, and that best practice is a holistic value-leakage package that addresses investments, restricted payments, and asset sales to unrestricted subsidiaries together — and avoids relying on undefined LME concepts.
For sure, the reference to the German wood products manufacturer transaction caught the attention of covenant lawyers and distressed investors — 9fin reached out to sources to gather information about what this actually means.
What happened in Pfleiderer?
Everyone had heard about what happened in Pfleiderer, said one buysider. In December last year, the company secured a liquidity injection of €135m through a carve-out of its resin division, Silekol.
A previous A&E in August 2024






